232 related articles for article (PubMed ID: 15059891)
21. PARI functions as a new transcriptional target of FOXM1 involved in gastric cancer development.
Zhang Y; Ye X; Chen L; Wu Q; Gao Y; Li Y
Int J Biol Sci; 2018; 14(5):531-541. PubMed ID: 29805304
[TBL] [Abstract][Full Text] [Related]
22. Involvement of inactive GSK3beta overexpression in tumorigenesis and progression of gastric carcinomas.
Zheng HC; Xu XY; Xia P; Yu M; Takahashi H; Takano Y
Hum Pathol; 2010 Sep; 41(9):1255-64. PubMed ID: 20447678
[TBL] [Abstract][Full Text] [Related]
23. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis.
Xie J; Tan ZH; Tang X; Mo MS; Liu YP; Gan RL; Li Y; Zhang L; Li GQ
World J Gastroenterol; 2014 Dec; 20(46):17439-47. PubMed ID: 25516656
[TBL] [Abstract][Full Text] [Related]
24. Human stomach-specific gene, CA11, is down-regulated in gastric cancer.
Shiozaki K; Nakamori S; Tsujie M; Okami J; Yamamoto H; Nagano H; Dono K; Umeshita K; Sakon M; Furukawa H; Hiratsuka M; Kasugai T; Ishiguro S; Monden M
Int J Oncol; 2001 Oct; 19(4):701-7. PubMed ID: 11562744
[TBL] [Abstract][Full Text] [Related]
25. THBS4 predicts poor outcomes and promotes proliferation and metastasis in gastric cancer.
Chen X; Huang Y; Wang Y; Wu Q; Hong S; Huang Z
J Physiol Biochem; 2019 Feb; 75(1):117-123. PubMed ID: 30746617
[TBL] [Abstract][Full Text] [Related]
26. REGIV as a potential biomarker for peritoneal dissemination in gastric adenocarcinoma.
Moon JH; Fujiwara Y; Nakamura Y; Okada K; Hanada H; Sakakura C; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
J Surg Oncol; 2012 Feb; 105(2):189-94. PubMed ID: 21780125
[TBL] [Abstract][Full Text] [Related]
27. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
[TBL] [Abstract][Full Text] [Related]
28. CDH17 alters MMP-2 expression via canonical NF-κB signalling in human gastric cancer.
Jiang XJ; Lin J; Cai QH; Zhao JF; Zhang HJ
Gene; 2019 Jan; 682():92-100. PubMed ID: 29783070
[TBL] [Abstract][Full Text] [Related]
29. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.
Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF
PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595
[TBL] [Abstract][Full Text] [Related]
30. Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma.
He WL; Li YH; Yang DJ; Song W; Chen XL; Liu FK; Wang Z; Li W; Chen W; Chen CY; He YL; Zhan WH
Eur J Surg Oncol; 2013 Feb; 39(2):141-9. PubMed ID: 22999412
[TBL] [Abstract][Full Text] [Related]
31. The role of Reg IV gene and its encoding product in gastric carcinogenesis.
Zheng HC; Xu XY; Yu M; Takahashi H; Masuda S; Takano Y
Hum Pathol; 2010 Jan; 41(1):59-69. PubMed ID: 19740514
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA‑34a attenuates the proliferation, invasion and metastasis of gastric cancer cells via downregulation of MET.
Wei B; Huang QY; Huang SR; Mai W; Zhong XG
Mol Med Rep; 2015 Oct; 12(4):5255-61. PubMed ID: 26238271
[TBL] [Abstract][Full Text] [Related]
33. Search for potential gastric cancer markers using miRNA databases and gene expression analysis.
Volkomorov V; Grigoryeva E; Krasnov G; Litviakov N; Tsyganov M; Karbyshev M; Zavyalova M; Afanasуev S; Cherdyntseva N; Lisitsyn N; Beresten S
Exp Oncol; 2013 Mar; 35(1):2-7. PubMed ID: 23528308
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of autophagy-related proteins expression in resected human gastric adenocarcinoma.
Qu B; Yao L; Ma HL; Chen HL; Zhang Z; Xie J
J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):37-43. PubMed ID: 28224423
[TBL] [Abstract][Full Text] [Related]
35. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers.
Wang JY; Hsieh JS; Chen CC; Tzou WS; Cheng TL; Chen FM; Huang TJ; Huang YS; Huang SY; Yang T; Lin SR
J Surg Res; 2004 Aug; 120(2):242-8. PubMed ID: 15234219
[TBL] [Abstract][Full Text] [Related]
36. [Expression of S100A6 in primary and metastatic human gastric cancer].
Huang HL; Wu BY; Zhu XD; You WD; Wang WH; Wang MW
Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):506-10. PubMed ID: 19062716
[TBL] [Abstract][Full Text] [Related]
37. Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer.
Kanda M; Shimizu D; Tanaka H; Shibata M; Iwata N; Hayashi M; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncotarget; 2016 Mar; 7(12):13667-79. PubMed ID: 26872374
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
[TBL] [Abstract][Full Text] [Related]
39. Comparison of gene expression profiles between primary tumor and metastatic lesions in gastric cancer patients using laser microdissection and cDNA microarray.
Wang L; Zhu JS; Song MQ; Chen GQ; Chen JL
World J Gastroenterol; 2006 Nov; 12(43):6949-54. PubMed ID: 17109515
[TBL] [Abstract][Full Text] [Related]
40. [Regulation mechanism study of S100A6 on invasion and metastasis in gastric cancer].
Li J; Wang XH; Li ZY; Bu ZD; Wu AW; Zhang LH; Wu XJ; Zong XL; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Nov; 16(11):1096-101. PubMed ID: 24277409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
